Cargando…

Scoring Methods for Building Genotypic Scores: An Application to Didanosine Resistance in a Large Derivation Set

BACKGROUND: Several attempts have been made to determine HIV-1 resistance from genotype resistance testing. We compare scoring methods for building weighted genotyping scores and commonly used systems to determine whether the virus of a HIV-infected patient is resistant. METHODS AND PRINCIPAL FINDIN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Houssaini, Allal, Assoumou, Lambert, Miller, Veronica, Calvez, Vincent, Marcelin, Anne-Geneviève, Flandre, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605419/ https://www.ncbi.nlm.nih.gov/pubmed/23555613 http://dx.doi.org/10.1371/journal.pone.0059014

Ejemplares similares

Investigation of Super Learner Methodology on HIV-1 Small Sample: Application on Jaguar Trial Data
por: Houssaïni, Allal, et al.
Publicado: (2012)

Week 48 efficacy of 900/100 mg daily of darunavir/ritonavir in treatment-experienced HIV-1 patients with virological success: DARDAR study
por: Schneider, L, et al.
Publicado: (2010)

Bioretrosynthetic construction of a didanosine biosynthetic pathway
por: Birmingham, William R., et al.
Publicado: (2014)

Clinical presentation of Covid-19 in health care workers from a French University Hospital
por: Jary, Aude, et al.
Publicado: (2020)

Interactions of Tenofovir, Lamivudine, Abacavir and Didanosine in Primary Human Cells
por: Janneh, Omar, et al.
Publicado: (2011)

Description of the L76V Resistance Protease Mutation in HIV-1 B and “Non-B” Subtypes
por: Charpentier, Charlotte, et al.
Publicado: (2013)

Analysis of in vivo absorption of didanosine tablets in male adult dogs by HPLC
por: Severino, Patrícia, et al.
Publicado: (2012)

HIV-1 Coreceptor Usage Assessment by Ultra-Deep Pyrosequencing and Response to Maraviroc
por: Rodriguez, Christophe, et al.
Publicado: (2015)

Decreased Sensitivity of Rapid Antigen Test Is Associated with a Lower Viral Load of Omicron than Delta SARS-CoV-2 Variant
por: Cocherie, Théophile, et al.
Publicado: (2022)

A Case of Non-Cirrhotic Portal Hypertension Associated With Chronic Didanosine Therapy
por: Stotts, Matthew, et al.
Publicado: (2015)

Similar Evolution of Cellular HIV-1 DNA Level in Darunavir/Ritonavir Monotherapy versus Triple Therapy in MONOI –ANRS136 Trial over 96 Weeks
por: Lambert-Niclot, Sidonie, et al.
Publicado: (2012)

Preparation of gastro-resistant pellets containing chitosan microspheres for improvement of oral didanosine bioavailability
por: Severino, Patrícia, et al.
Publicado: (2012)

Efficacious Preclinical Repurposing of the Nucleoside Analogue Didanosine against COVID-19 Polymerase and Exonuclease
por: Rabie, Amgad M.
Publicado: (2022)

Portal Hypertension Due to Hepatoportal Sclerosis in an HIV-Positive Patient Secondary to Didanosine Use
por: Phrathep, Davong D, et al.
Publicado: (2023)

SARS-CoV-2 Neutralizing Responses in Various Populations, at the Time of SARS-CoV-2 Variant Virus Emergence: Evaluation of Two Surrogate Neutralization Assays in Front of Whole Virus Neutralization Test
por: Marot, Stephane, et al.
Publicado: (2022)

A case of nodular regenerative hyperplasia in a patient who had been taking didanosine
por: Jackson, C, et al.
Publicado: (2010)

Poor Efficacy and Tolerability of Stavudine, Didanosine, and Efavirenz-based Regimen in Treatment-Naive Patients in Senegal
por: Canestri, Anna, et al.
Publicado: (2007)

Insulin resistance in people living with HIV is associated with exposure to thymidine analogues and/or didanosine and prior immunodeficiency
por: Høgh, Julie, et al.
Publicado: (2022)

A Polymorphism at Position 400 in the Connection Subdomain of HIV-1 Reverse Transcriptase Affects Sensitivity to NNRTIs and RNaseH Activity
por: Wright, David W., et al.
Publicado: (2013)

Efficacy of once daily darunavir/ritonavir 800/100 mg in PI/r-experienced HIV-1 infected patients with suppressed HIV-1 replication: the RADAR study
por: Ghosn, J, et al.
Publicado: (2010)

Toxic intracellular anabolite levels of tenofovir and didanosine causing a steep CD4-cell decline
por: de Jong, E, et al.
Publicado: (2010)

Repurposing Didanosine as a Potential Treatment for COVID-19 Using Single-Cell RNA Sequencing Data
por: Alakwaa, Fadhl M.
Publicado: (2020)

Characterization of a Propionibacterium acnes Surface Protein as a Fibrinogen-Binding Protein
por: Grange, Philippe A., et al.
Publicado: (2017)

Characterization of a Cutibacterium acnes Camp Factor 1-Related Peptide as a New TLR-2 Modulator in In Vitro and Ex Vivo Models of Inflammation
por: Mayslich, Constance, et al.
Publicado: (2022)

Less frequent follow-up in routine care than in trials does not impact resistance selection in patients failing DRV/r or ATV/r first line treatment
por: Marcelin, Anne-Genevieve, et al.
Publicado: (2014)

Interpretation of SARS-CoV-2 replication according to RT-PCR crossing threshold value
por: Marot, Stéphane, et al.
Publicado: (2021)

In Silico Investigation of the New UK (B.1.1.7) and South African (501Y.V2) SARS-CoV-2 Variants with a Focus at the ACE2–Spike RBD Interface
por: Villoutreix, Bruno O., et al.
Publicado: (2021)

A prospective study of hearing changes after beginning zidovudine or didanosine in HIV-1 treatment-naïve people
por: Schouten, Jeffrey T, et al.
Publicado: (2006)

Abacavir, efavirenz, didanosine, with or without hydroxyurea, in HIV-infected adults failing initial nucleoside/protease inhibitor-containing regimens
por: Swindells, Susan, et al.
Publicado: (2005)

Prevalence of significant liver disease in human immunodeficiency virus-infected patients exposed to Didanosine: A cross sectional study
por: Logan, Sarah, et al.
Publicado: (2016)

Kaposi’s Sarcoma-Associated Herpesvirus, the Etiological Agent of All Epidemiological Forms of Kaposi’s Sarcoma
por: Jary, Aude, et al.
Publicado: (2021)

A Rare Case of Didanosine-Induced Mid-Peripheral Chorioretinal Atrophy Identified Incidentally 11 Years after the Drug Cessation
por: Joharjy, Heba, et al.
Publicado: (2022)

New severity score of acute respiratory failure
por: Allal, S, et al.
Publicado: (2012)

Harnessing Redox Disruption to Treat Human Herpesvirus 8 (HHV-8) Related Malignancies
por: Gothland, Adélie, et al.
Publicado: (2022)

Building a Patient-Specific Risk Score with a Large Database of Discharge Summary Reports
por: Qu, Zhi, et al.
Publicado: (2016)

A New Topical Candidate in Acne Treatment: Characterization of the Meclozine Hydrochloride as an Anti-Inflammatory Compound from In Vitro to a Preliminary Clinical Study
por: Grange, Philippe A., et al.
Publicado: (2022)

Polygenic score development in the era of large-scale biobanks
por: Plagnol, Vincent
Publicado: (2022)

High-Level Cross-Resistance to Didanosine Observed in South African Children Failing an Abacavir- or Stavudine-Based 1(st)-Line Regimen
por: Steegen, Kim, et al.
Publicado: (2014)

Epidemiology and Characteristics of SARS-CoV-2 Variants of Concern: The Impacts of the Spike Mutations
por: Cocherie, Théophile, et al.
Publicado: (2022)

976. Development and Validation of a Risk Score for Predicting Cardiovascular Events in HIV-Infected Patients
por: Karanika, Styliani, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ll6f361n283vja066ulnqp08i9